-
U87MG; U251
Wnt/beta-catenin (promotes); cell cycle (promotes); proliferation (promotes); angiogenesis (promotes)
RT-qPCR; Transfection; BrdU; Tube Formation Assay; Cell Cycle Assay; ELISA; Western Blot; Luciferase Reporter Assay
Potential therapeutic target and biomarker in glioma.
In human glioma cell lines, cZNF292 supports proliferation, cell-cycle progression and tube formation. Knockdown of cZNF292 induces S/G2/M arrest and suppresses Wnt/beta-catenin-related signaling and downstream effectors (e.g., Cyclin A/CDK2/PRR11) as well as tube formation-associated factors (VEGFR-1/2, EGFR).
0.5301
Silencing of cZNF292 circular RNA suppresses human glioma tube formation via the Wnt/beta-catenin signaling pathway.
biological research